NCT04645602: Merck IIT: RRP Pembro and Lenvatinib
- State
- Under way
- Phase
- Phase 2
- People
- 20 planned
- Started
- 18 Jul 2025
- Primary completion
- Dec 2027
- Arms
- Lenvatinib + Pembrolizumab
- Results
- None posted
- 27 Nov 2020: Trial registered
- 18 Jul 2025: Trial started